Skip to Content

21 Results Found

  • Article
  • Open Access
49 Citations
8,038 Views
20 Pages

Ras and Raf-kinase interact through the Ras-binding (RBD) and cysteine-rich domains (CRD) of Raf to signal through the mitogen-activated protein kinase pathway, yet the molecular mechanism leading to Raf activation has remained elusive. We present th...

(This article belongs to the Special Issue Recent Insights into the Regulation and Structure of RAS Membrane Signaling Complexes—Emerging Drug Targeting Opportunities)
  • Article
  • Open Access
2,727 Views
17 Pages

Two Cysteines in Raf Kinase Inhibitor Protein Make Differential Contributions to Structural Dynamics In Vitro

  • Hyun Sang Cho,
  • Mohammad Faysal Al Mazid,
  • Eun-Young Lee,
  • Md Abu Rayhan and ,
  • Hyoun Sook Kim,
  • Byung Il Lee and
  • Hye Jin You
  • + 2 authors+ 0 author

17 January 2025

As a scaffolding protein, Raf kinase binding protein (RKIP) is involved in a variety of cellular pathways, including the Raf–MEK–ERK-cascade. It acts as a negative regulator by binding to its partners, making it an attractive target in th...

  • Feature Paper
  • Review
  • Open Access
45 Citations
7,988 Views
18 Pages

6 November 2020

Ras is the most frequently mutated oncogene and recent drug development efforts have spurred significant new research interest. Here we review progress toward understanding how Ras functions in nanoscale, proteo-lipid signaling complexes on the plasm...

(This article belongs to the Special Issue Recent Insights into the Regulation and Structure of RAS Membrane Signaling Complexes—Emerging Drug Targeting Opportunities)
  • Article
  • Open Access
8 Citations
3,134 Views
16 Pages

Regorafenib Combined with BRAF/MEK Inhibitors for the Treatment of Refractory Melanoma Brain Metastases

  • Iris Dirven,
  • Eden Pierre,
  • An-Sofie Vander Mijnsbrugge,
  • Manon Vounckx and ,
  • Jolien I. Kessels and
  • Bart Neyns
  • + 1 author+ 0 author

5 December 2024

Background: There are no active treatment options for patients with progressive melanoma brain metastases (MBM) failing immune checkpoint blockade (ICB) and BRAF/MEK inhibitors (BRAF/MEKi). Regorafenib (REGO), an oral multi-kinase inhibitor (incl. RA...

(This article belongs to the Section Clinical Research in Cancer)
  • Article
  • Open Access
9 Citations
4,777 Views
19 Pages

A Combination of Conformation-Specific RAF Inhibitors Overcome Drug Resistance Brought about by RAF Overexpression

  • Hiroaki Imoto,
  • Nora Rauch,
  • Ashish J. Neve,
  • Fahimeh Khorsand and ,
  • Martina Kreileder,
  • Leonidas G. Alexopoulos,
  • Jens Rauch,
  • Mariko Okada,
  • Boris N. Kholodenko and
  • Oleksii S. Rukhlenko
  • + 5 authors+ 0 author

2 August 2023

Cancer cells often adapt to targeted therapies, yet the molecular mechanisms underlying adaptive resistance remain only partially understood. Here, we explore a mechanism of RAS/RAF/MEK/ERK (MAPK) pathway reactivation through the upregulation of RAF...

(This article belongs to the Section Enzymology)
  • Review
  • Open Access
16 Citations
5,011 Views
12 Pages

30 September 2021

Signals conveyed through the RAS-ERK pathway constitute a pivotal regulatory element in cancer-related cellular processes. Recently, RAS dimerization has been proposed as a key step in the relay of RAS signals, critically contributing to RAF activati...

(This article belongs to the Special Issue RAS Signaling in Health and Disease)
  • Review
  • Open Access
13 Citations
6,351 Views
17 Pages

Small Molecule B-RAF Inhibitors as Anti-Cancer Therapeutics: Advances in Discovery, Development, and Mechanistic Insights

  • Yamile Abuchard Anaya,
  • Ricardo Pequeno Bracho,
  • Subhash C. Chauhan,
  • Manish K. Tripathi and
  • Debasish Bandyopadhyay

B-RAF is a serine/threonine kinase that plays a crucial role in the MAPK signaling pathway, regulating cell proliferation and survival. Mutations in B-RAF, particularly V600E, are associated with several malignancies, including melanoma, colorectal c...

(This article belongs to the Special Issue Anti-Cancer Drugs: Natural Products, Synthetic Compounds and Potential Pharmacological Effects and Applications)
  • Review
  • Open Access
492 Citations
34,475 Views
33 Pages

Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy

  • Ufuk Degirmenci,
  • Mei Wang and
  • Jiancheng Hu

13 January 2020

The RAS/RAF/MEK/ERK (MAPK) signaling cascade is essential for cell inter- and intra-cellular communication, which regulates fundamental cell functions such as growth, survival, and differentiation. The MAPK pathway also integrates signals from comple...

(This article belongs to the Special Issue GTPase Pathways in Health and Diseases)
  • Article
  • Open Access
66 Citations
5,974 Views
21 Pages

A Comprehensive In Silico Exploration of Pharmacological Properties, Bioactivities, Molecular Docking, and Anticancer Potential of Vieloplain F from Xylopia vielana Targeting B-Raf Kinase

  • Syed Shams ul Hassan,
  • Syed Qamar Abbas,
  • Fawad Ali,
  • Muhammad Ishaq and ,
  • Iqra Bano,
  • Mubashir Hassan,
  • Hui-Zi Jin and
  • Simona G. Bungau
  • + 3 authors+ 0 author

28 January 2022

Compounds derived from plants have several anticancer properties. In the current study, one guaiane-type sesquiterpene dimer, vieloplain F, isolated from Xylopia vielana species, was tested against B-Raf kinase protein (PDB: 3OG7), a potent target fo...

(This article belongs to the Special Issue Natural Products for Chronic Diseases: A Ray of Hope)
  • Article
  • Open Access
35 Citations
5,319 Views
13 Pages

30 July 2019

The biological process, 3-O-galactosylation, is important in plant cells. To understand the mechanism of the reduction of flavonol antioxidative activity by 3-O-galactosylation, myricetin-3-O-galactoside (M3OGa) and myricetin aglycone were each incub...

(This article belongs to the Section Natural Products Chemistry)
  • Article
  • Open Access
3 Citations
2,622 Views
24 Pages

Design, Synthesis, and Anti-Leukemic Evaluation of a Series of Dianilinopyrimidines by Regulating the Ras/Raf/MEK/ERK and STAT3/c-Myc Pathways

  • Chaoyan Wang,
  • Bo Wang,
  • Yu Mou,
  • Xiang Liu and ,
  • Qiqing Chen,
  • Weidong Pu,
  • Qing Rao,
  • Chunlin Wang,
  • Jingrui Song and
  • Yanmei Li
  • + 8 authors+ 3 authors

Although the long-term survival rate for leukemia has made significant progress over the years with the development of chemotherapeutics, patients still suffer from relapse, leading to an unsatisfactory outcome. To discover the new effective anti-leu...

  • Article
  • Open Access
61 Citations
7,281 Views
13 Pages

Antioxidant and Cytoprotective Effects of Tibetan Tea and Its Phenolic Components

  • Hong Xie,
  • Xican Li,
  • Zhenxing Ren,
  • Weimin Qiu and ,
  • Jianlan Chen,
  • Qian Jiang,
  • Ban Chen and
  • Dongfeng Chen
  • + 3 authors+ 0 author

24 January 2018

Tibetan tea (Kangzhuan) is an essential beverage of the Tibetan people. In this study, a lyophilized aqueous extract of Tibetan tea (LATT) was prepared and analyzed by HPLC. The results suggested that there were at least five phenolic components, inc...

(This article belongs to the Special Issue Catechin in Human Health and Disease)
  • Article
  • Open Access
55 Citations
7,318 Views
14 Pages

Antioxidant Mechanisms of Echinatin and Licochalcone A

  • Minshi Liang,
  • Xican Li,
  • Xiaojian Ouyang,
  • Hong Xie and
  • Dongfeng Chen

20 December 2018

Echinatin and its 1,1-dimethyl-2-propenyl derivative licochalcone A are two chalcones found in the Chinese herbal medicine Gancao. First, their antioxidant mechanisms were investigated using four sets of colorimetric measurements in this study. Three...

(This article belongs to the Special Issue The Antioxidant Capacities of Natural Products 2019)
  • Review
  • Open Access
1,875 Citations
73,224 Views
45 Pages

The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase that is commonly upregulated in cancers such as in non-small-cell lung cancer, metastatic colorectal cancer, glioblastoma, head and neck cancer, pancreatic cancer, and breast c...

(This article belongs to the Special Issue EGFR Family Signaling in Cancer)
  • Article
  • Open Access
4 Citations
4,191 Views
17 Pages

Cross-Species Comparison of the Pan-RAF Inhibitor LY3009120’s Anti-Tumor Effects in Equine, Canine, and Human Malignant Melanoma Cell Lines

  • Yu Gao,
  • Eva-Maria Packeiser,
  • Sophia Wendt,
  • Anett Sekora and ,
  • Jessika-Maximiliane V. Cavalleri,
  • Barbara Pratscher,
  • Moosheer Alammar,
  • Maja Hühns,
  • Bertram Brenig and
  • Hugo Murua Escobar
  • + 7 authors+ 2 authors

3 February 2024

Malignant melanomas (MMs) are the abnormal proliferation of melanocytes and are one of the lethal skin cancers in humans, equines, and canines. Accordingly, MMs in companion animals can serve as naturally occurring animal models, completing conventio...

(This article belongs to the Special Issue Companion Animal Genetics and Genomics)
  • Article
  • Open Access
5 Citations
3,184 Views
25 Pages

The Influence of Pedo-Climatic Conditions on the Micromorphological, Phytochemical Features, and Biological Properties of Leaves of Saponaria sicula Raf

  • Laura Cornara,
  • Paola Malaspina,
  • Federica Betuzzi,
  • Emilio Di Gristina and ,
  • Manuela D’Arrigo,
  • Mariarosaria Ingegneri,
  • Domenico Trombetta and
  • Antonella Smeriglio
  • + 3 authors+ 0 author

Saponaria sicula Raf. grows in Sicily, Sardinia, and Algeria on limestone cliffs and volcanic sands 1300–2500 m above sea level. The aim of the present study was to investigate how the pedo-climatic conditions influence the micromorphological,...

(This article belongs to the Special Issue Biotic and Abiotic Stressors in Plant Metabolism)
  • Article
  • Open Access
12 Citations
5,321 Views
14 Pages

Novel and Potent Small Molecules against Melanoma Harboring BRAF Class I/II/III Mutants for Overcoming Drug Resistance

  • Namkyoung Kim,
  • Injae Shin,
  • Jiwon Lee,
  • Eunhye Jeon and ,
  • Younghoon Kim,
  • Seongshick Ryu,
  • Eunhye Ju,
  • Wonjeong Cho and
  • Taebo Sim
  • + 4 authors+ 0 author

Melanoma accounts for the majority of skin cancer deaths. About 50% of all melanomas are associated with BRAF mutations. BRAF mutations are classified into three classes with regard to dependency on RAF dimerization and RAS signaling. The most freque...

(This article belongs to the Special Issue Precision Oncology in Melanoma Progression)
  • Review
  • Open Access
2 Citations
1,324 Views
41 Pages

30 July 2026

The epidermal growth factor receptor (EGFR) was the first receptor tyrosine kinase identified soon after v-Src was recognized as a tyrosine kinase. EGFR signaling begins when EGF binds to EGFR at the cell surface, inducing receptor dimerization, acti...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
38 Citations
7,412 Views
13 Pages

6 December 2018

To explore whether and how glucuronidation affects pyrogallol-type phytophenols, scutellarein and scutellarin (scutellarein-7-O-glucuronide) were comparatively investigated using a set of antioxidant analyses, including spectrophotometric analysis, U...

(This article belongs to the Special Issue The Antioxidant Capacities of Natural Products 2019)
  • Review
  • Open Access
19 Citations
5,761 Views
24 Pages

24 November 2024

Recent advances in drug discovery have established biosensors as indispensable tools, particularly valued for their precision, sensitivity, and real-time monitoring capabilities. The review begins with a brief overview of cancer drug discovery, under...

(This article belongs to the Section Biosensor and Bioelectronic Devices)
  • Article
  • Open Access
27 Citations
4,208 Views
12 Pages

26 November 2018

To clarify the role of the B-ring in antioxidant flavonols, we performed a comparative study between galangin with a null B-ring and 3,5,7-trihydroxychromone without a B-ring using five spectrophotometric assays, namely, •O2−-scavenging, 1...

(This article belongs to the Special Issue The Antioxidant Capacities of Natural Products 2019)